NPFCX
Price
$69.19
Change
+$0.11 (+0.16%)
Updated
Dec 4 closing price
Net Assets
162.64B
SCMGX
Price
$33.58
Change
+$0.12 (+0.36%)
Updated
Dec 4 closing price
Net Assets
908.96M
Interact to see
Advertisement

NPFCX vs SCMGX

Header iconNPFCX vs SCMGX Comparison
Open Charts NPFCX vs SCMGXBanner chart's image
American Funds New Perspective C
Price$69.19
Change+$0.11 (+0.16%)
VolumeN/A
Net Assets162.64B
Sands Capital Global Growth Inst
Price$33.58
Change+$0.12 (+0.36%)
VolumeN/A
Net Assets908.96M
NPFCX vs SCMGX Comparison Chart in %
View a ticker or compare two or three
VS
NPFCX vs. SCMGX commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NPFCX is a Buy and SCMGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
NPFCX has more cash in the bank: 163B vs. SCMGX (909M). NPFCX (0.00) and SCMGX (0.00) have matching dividends . NPFCX was incepted earlier than SCMGX: NPFCX (25 years) vs SCMGX (16 years). NPFCX (1.48) is less costly to investors than SCMGX (0.96). NPFCX is a more actively managed with annual turnover of: 24.00 vs. SCMGX (17.00). NPFCX has a lower initial minimum investment than SCMGX: NPFCX (250) vs SCMGX (1000000). NPFCX annual gain was more profitable for investors over the last year : 10.87 vs. SCMGX (-1.76). NPFCX return over 5 years is better than : 19.69 vs. SCMGX (-14.05).
NPFCXSCMGXNPFCX / SCMGX
Total Expense Ratio1.480.96154%
Annual Report Gross Expense Ratio1.480.96154%
Fund Existence25 years16 years-
Gain YTD19.30910.831178%
Front LoadN/AN/A-
Min. Initial Investment25010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets163B909M17,932%
Annual Yield % from dividends0.000.00-
Returns for 1 year10.87-1.76-617%
Returns for 3 years42.1644.9194%
Returns for 5 years19.69-14.05-140%
Returns for 10 years84.0386.6897%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CPRX23.100.48
+2.12%
Catalyst Pharmaceuticals
DCBO21.600.28
+1.31%
Docebo
ADIL0.32N/A
+0.70%
Adial Pharmaceuticals
THC211.34-3.50
-1.63%
Tenet Healthcare Corp
FURY0.58-0.01
-1.77%
Fury Gold Mines Limited